Saturday, January 19, 2019
Tags Luxturna

Tag: Luxturna

Express Scripts Chief Medical Officer Steve Miller poses for a portrait in the Manhattan borough of New York

Express Scripts Staking Out Million-Dollar Gene Therapies

By Caroline Humer and Deena Beasley (Reuters)  Express Scripts Holding Co built a multi-billion enterprise pressuring drug companies to lower their prices for U.S. patients. Now...
Swiss pharmaceutical group Lonza's world’s largest dedicated cell and gene therapy facility in Houston

Lonza’s Virus Factory Shows Gene Therapy’s Texas-Sized Promise

By John Miller ZURICH (Reuters) Swiss drugmaker-for-hire Lonza is betting that trillions of customized viruses made at a giant factory in Texas will be the lucrative...
A man receives an eye exam

Drugmakers See a Pricing Blueprint in An $850,000 Gene Therapy

By Caroline Humer SAN FRANCISCO (Reuters) Global drugmakers are looking to a tiny biotech's $850,000 therapy for a rare type of blindness as a model for...
Patients receive eye exams in a file photo

Spark’s Price for Luxturna Blindness Gene Therapy Too High: ICER

By Bill Berkrot (Reuters) The proposed price for Spark Therapeutics Inc's <ONCE.O> groundbreaking one-time gene therapy for a rare form of blindness is far too high,...